In Vitro Inhibition of HIV-1 Infectivity by Human Salivas
- 1 December 1990
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 6 (12) , 1425-1432
- https://doi.org/10.1089/aid.1990.6.1425
Abstract
Inhibitory factors to human immunodeficiency virus type 1 (HIV-1) in saliva may be responsible for the infrequent isolation of virus from saliva and also may account for the marked infrequency of salivary and/or oral transmission of HIV-1. Incubation of HIV-1 with human saliva followed by addition of the mixture to susceptible cells leads to partial or complete suppression of viral replication in vitro. We investigated the inhibitory effects of whole saliva and specific glandular salivas on HIV-1 infectivity as measured by viral-induced cytopathic effects in susceptible cells. Whole saliva contained marked inhibitory activity to HIV-1, strain HTLV-IIIB, and to virus infected cells. Submandibular saliva contained inhibitory activity, but of lesser quantity. Parotid saliva demonstrated no HIV-inhibitory activity. Whole saliva also appeared to contain filterable components that were inhibitory to lymphocyte growth. Passage through a.45 μm pore-size filter eliminated the viral inhibitory activity of submandibular saliva and some of the activity in whole saliva. All salivas except parotid incubated with HIV-1 followed by filtration were inhibitory suggesting that complexing of virus with high molecular weight, submandibular mucins may play a role in viral inhibition.Keywords
This publication has 31 references indexed in Scilit:
- Variation of Secretory Antibodies in Parotid Saliva to Human Immunodeficiency Virus Type 1 with HIV-1 Disease StageAIDS Research and Human Retroviruses, 1990
- HIV IN SALIVAThe Lancet, 1988
- Activity of Dextran Sulfate and Other Polyanionic Polysaccharides Against Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1988
- Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines.The Journal of Experimental Medicine, 1988
- Low Occupational Risk of Human Immunodeficiency Virus Infection among Dental ProfessionalsNew England Journal of Medicine, 1988
- Secretory IgA Antibodies to Human Immunodeficiency Virus in the Parotid Saliva of Patients with AIDS and AIDS-Related ComplexThe Journal of Infectious Diseases, 1987
- Lack of Transmission of HTLV-III/LAV Infection to Household Contacts of Patients with AIDS or AIDS-Related Complex with Oral CandidiasisNew England Journal of Medicine, 1986
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- EFFECTS OF NATURAL AND SYNTHETIC SULFATED POLYSACCHARIDES ON VIRUSES AND CELLSAnnals of the New York Academy of Sciences, 1965